Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 144

1.

Effects of AMPA and D1 receptor activation on striatal and nigral GABA efflux.

Byrnes EM, Reilly A, Bruno JP.

Synapse. 1997 Jul;26(3):254-68.

PMID:
9183815
[PubMed - indexed for MEDLINE]
3.

Decreased striatal dopamine efflux after intrastriatal application of benzazepine-class D1 agonists is not mediated via dopamine receptors.

Zackheim JA, Abercrombie ED.

Brain Res Bull. 2001 Apr;54(6):603-7.

PMID:
11403986
[PubMed - indexed for MEDLINE]
4.

Substantia nigra D1 receptors and stimulation of striatal cholinergic interneurons by dopamine: a proposed circuit mechanism.

Abercrombie ED, DeBoer P.

J Neurosci. 1997 Nov 1;17(21):8498-505.

PMID:
9334422
[PubMed - indexed for MEDLINE]
Free Article
5.

Modulation of GABA release by dopamine in the substantia nigra.

Matuszewich L, Yamamoto BK.

Synapse. 1999 Apr;32(1):29-36.

PMID:
10188635
[PubMed - indexed for MEDLINE]
6.

Striatal and nigral D1 mechanisms involved in the antiparkinsonian effects of SKF 82958 (APB): studies of tremulous jaw movements in rats.

Mayorga AJ, Trevitt JT, Conlan A, Gianutsos G, Salamone JD.

Psychopharmacology (Berl). 1999 Mar;143(1):72-81.

PMID:
10227082
[PubMed - indexed for MEDLINE]
7.

Influence of dopamine on GABA release in striatum: evidence for D1-D2 interactions and non-synaptic influences.

Harsing LG Jr, Zigmond MJ.

Neuroscience. 1997 Mar;77(2):419-29.

PMID:
9472401
[PubMed - indexed for MEDLINE]
8.

The striatonigral dynorphin pathway of the rat studied with in vivo microdialysis--II. Effects of dopamine D1 and D2 receptor agonists.

You ZB, Herrera-Marschitz M, Nylander I, Goiny M, O'Connor WT, Ungerstedt U, Terenius L.

Neuroscience. 1994 Nov;63(2):427-34.

PMID:
7891856
[PubMed - indexed for MEDLINE]
9.

Interactions between dopamine D1 receptors and gamma-aminobutyric acid mechanisms in substantia nigra pars reticulata of the rat: neurochemical and behavioral studies.

Trevitt T, Carlson B, Correa M, Keene A, Morales M, Salamone JD.

Psychopharmacology (Berl). 2002 Jan;159(3):229-37. Epub 2001 Nov 1.

PMID:
11862355
[PubMed - indexed for MEDLINE]
10.

Changes in extracellular levels of glutamate and aspartate in rat substantia nigra induced by dopamine receptor ligands: in vivo microdialysis studies.

Abarca J, Gysling K, Roth RH, Bustos G.

Neurochem Res. 1995 Feb;20(2):159-69.

PMID:
7783840
[PubMed - indexed for MEDLINE]
11.

High-dose methamphetamine acutely activates the striatonigral pathway to increase striatal glutamate and mediate long-term dopamine toxicity.

Mark KA, Soghomonian JJ, Yamamoto BK.

J Neurosci. 2004 Dec 15;24(50):11449-56.

PMID:
15601951
[PubMed - indexed for MEDLINE]
Free Article
12.

Dopaminergic regulation of serotonin release in the substantia nigra of the freely moving rat using microdialysis.

Thorré K, Sarre S, Smolders I, Ebinger G, Michotte Y.

Brain Res. 1998 Jun 15;796(1-2):107-16.

PMID:
9689460
[PubMed - indexed for MEDLINE]
14.

In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to L-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels.

Mela F, Marti M, Bido S, Cenci MA, Morari M.

Neurobiol Dis. 2012 Jan;45(1):573-82. doi: 10.1016/j.nbd.2011.09.015. Epub 2011 Oct 7.

PMID:
22001605
[PubMed - indexed for MEDLINE]
15.

Adenosine A1 receptors control dopamine D1-dependent [(3)H]GABA release in slices of substantia nigra pars reticulata and motor behavior in the rat.

Florán B, Barajas C, Florán L, Erlij D, Aceves J.

Neuroscience. 2002;115(3):743-51.

PMID:
12435413
[PubMed - indexed for MEDLINE]
16.

The substantia nigra pars reticulata mediates the enhancement of startle by the dopamine D1 receptor agonist SKF 82958 in rats.

Meloni EG, Davis M.

Psychopharmacology (Berl). 2004 Jul;174(2):228-36.

PMID:
14735289
[PubMed - indexed for MEDLINE]
17.

Biotransformation of L-DOPA to dopamine in the substantia nigra of freely moving rats: effect of dopamine receptor agonists and antagonists.

Sarre S, Vandeneede D, Ebinger G, Michotte Y.

J Neurochem. 1998 Apr;70(4):1730-9.

PMID:
9523592
[PubMed - indexed for MEDLINE]
18.

Evidence for a striatal NMDA receptor modulation of nigral glutamate release. A dual probe microdialysis study in the awake freely moving rat.

Morari M, Sbrenna S, Marti M, O'Connor WT, Bianchi C, Fuxe K, Beani L.

Eur J Neurosci. 1998 May;10(5):1716-22.

PMID:
9751143
[PubMed - indexed for MEDLINE]
19.

GABA(B) receptor activation inhibits dopamine D1 receptor-mediated facilitation of [(3)H]GABA release in substantia nigra pars reticulata.

Nava-Asbell C, Paz-Bermudez F, Erlij D, Aceves J, Florán B.

Neuropharmacology. 2007 Oct;53(5):631-7. Epub 2007 Aug 10.

PMID:
17868750
[PubMed - indexed for MEDLINE]
20.

In vivo microdialysis evidence for transient dopamine release by benzazepines in rat striatum.

Tomiyama K, Koshikawa N, Funada K, Oka K, Kobayashi M.

J Neurochem. 1995 Dec;65(6):2790-5.

PMID:
7595579
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk